Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04276415 · ClinicalTrials.gov registry record · Phase 1
DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)
A Phase 1 study, sponsored by Daiichi Sankyo.
- Terminated
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT04276415 is a Phase 1 study that was terminated before completion, run by Daiichi Sankyo. The registered enrollment target is 34 participants.
The verdict
NCT04276415, a Phase 1 study, was terminated before completion, sponsored by Daiichi Sankyo.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).
Interventions
- DRUG DS-6157a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2020-05-08 |
| Est. Completion | 2022-03-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04276415
The ClinicalTrials.gov registry entry for NCT04276415 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DS-6157a is the first listed.
NCT04276415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04276415 about?
NCT04276415 is a clinical study titled "DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)". This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).
What is the current status of trial NCT04276415?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2020-05-08. Estimated completion is 2022-03-11.
What interventions are being tested in trial NCT04276415?
The interventions under investigation include: DS-6157a (DRUG).
Who is sponsoring clinical trial NCT04276415?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.